131 related articles for article (PubMed ID: 2687410)
21. Production of a novel monoclonal antibody, JT-95, which can detect antigen of thyroid carcinoma.
Takeyama H; Hosoya T; Sakurai K; Mori Y; Watanabe M; Kisaki H; Ohno T
Cancer Res; 1996 Apr; 56(8):1817-22. PubMed ID: 8620498
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
23. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
24. A new tumor-associated antigen expressed on breast carcinomas, defined by monoclonal antibody BCA 227.
Blottière HM; Pelhate S; Aubry J; Kremer M; Thedrez P; Sai-Maurel C; Douillard JY; Chatal JF
Cancer Res; 1991 Mar; 51(5):1537-43. PubMed ID: 1997195
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
[TBL] [Abstract][Full Text] [Related]
27. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
28. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
29. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
[TBL] [Abstract][Full Text] [Related]
30. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
31. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
32. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
33. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
34. Immunodetection of squamous cell carcinoma-associated variant of nuclear protein.
Rakowicz-Szulczynska EM; McIntosh DG; Perry M; Smith ML
Gynecol Oncol; 1996 Feb; 60(2):255-63. PubMed ID: 8631548
[TBL] [Abstract][Full Text] [Related]
35. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
Iacobelli S; Arnò E; D'Orazio A; Coletti G
Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
37. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
[TBL] [Abstract][Full Text] [Related]
38. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies.
Varki NM; Reisfeld RA; Walker LE
Cancer Res; 1984 Feb; 44(2):681-7. PubMed ID: 6362852
[TBL] [Abstract][Full Text] [Related]
39. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
40. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
